Ashkenazi A - Search Results

1

Targeting death and decoy receptors of the tumour-necrosis factor superfamily.

Ashkenazi A. Ashkenazi A. Nat Rev Cancer. 2002 Jun;2(6):420-30. doi: 10.1038/nrc821. Nat Rev Cancer. 2002. PMID: 12189384 Review. No abstract available.

2

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer.

Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT, Godowski PJ, Wood WI, Gurney AL, Hillan KJ, Cohen RL, Goddard AD, Botstein D, Ashkenazi A. Pitti RM, et al. Among authors: ashkenazi a. Nature. 1998 Dec 17;396(6712):699-703. doi: 10.1038/25387. Nature. 1998. PMID: 9872321

3

Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax.

LeBlanc H, Lawrence D, Varfolomeev E, Totpal K, Morlan J, Schow P, Fong S, Schwall R, Sinicropi D, Ashkenazi A. LeBlanc H, et al. Among authors: ashkenazi a. Nat Med. 2002 Mar;8(3):274-81. doi: 10.1038/nm0302-274. Nat Med. 2002. PMID: 11875499

4

Targeting death receptors in cancer with Apo2L/TRAIL.

Kelley SK, Ashkenazi A. Kelley SK, et al. Among authors: ashkenazi a. Curr Opin Pharmacol. 2004 Aug;4(4):333-9. doi: 10.1016/j.coph.2004.02.006. Curr Opin Pharmacol. 2004. PMID: 15251125 Review.

5

Apoptosis control by death and decoy receptors.

Ashkenazi A, Dixit VM. Ashkenazi A, et al. Curr Opin Cell Biol. 1999 Apr;11(2):255-60. doi: 10.1016/s0955-0674(99)80034-9. Curr Opin Cell Biol. 1999. PMID: 10209153 Review.

6

Apo2L/TRAIL and its death and decoy receptors.

LeBlanc HN, Ashkenazi A. LeBlanc HN, et al. Among authors: ashkenazi a. Cell Death Differ. 2003 Jan;10(1):66-75. doi: 10.1038/sj.cdd.4401187. Cell Death Differ. 2003. PMID: 12655296 Review.

7

Death receptors: signaling and modulation.

Ashkenazi A, Dixit VM. Ashkenazi A, et al. Science. 1998 Aug 28;281(5381):1305-8. doi: 10.1126/science.281.5381.1305. Science. 1998. PMID: 9721089 Review.

8

Death receptor signal transducers: nodes of coordination in immune signaling networks.

Wilson NS, Dixit V, Ashkenazi A. Wilson NS, et al. Among authors: ashkenazi a. Nat Immunol. 2009 Apr;10(4):348-55. doi: 10.1038/ni.1714. Epub 2009 Mar 19. Nat Immunol. 2009. PMID: 19295631 Review.

9

Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival.

Jin H, Yang R, Fong S, Totpal K, Lawrence D, Zheng Z, Ross J, Koeppen H, Schwall R, Ashkenazi A. Jin H, et al. Among authors: ashkenazi a. Cancer Res. 2004 Jul 15;64(14):4900-5. doi: 10.1158/0008-5472.CAN-04-0408. Cancer Res. 2004. PMID: 15256461

10

Tumor necrosis factor: an apoptosis JuNKie?

Varfolomeev EE, Ashkenazi A. Varfolomeev EE, et al. Among authors: ashkenazi a. Cell. 2004 Feb 20;116(4):491-7. doi: 10.1016/s0092-8674(04)00166-7. Cell. 2004. PMID: 14980217 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

551 results

Search Page